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Abstract— Brucea javanica seeds has been used traditionally 
to treat cancer, even though the  scientific base of this has not 
been  completely  investigated. Bruceine A from Brucea 
javanica exhibit biological activities as a antimalarial, 
antitumor, antiviral and antiamoebic activities. This study is to 
examine the anticancer activity of Bruceine A from Brucea 
javanica seeds include cytotoxic activity and induced p53 
protein expression on Hela cell. Cytotoxicity test of Bruceine A 
from Brucea javanica seeds has been performed by counting 
method of the cell directly with trypan blue exclusion 
dye.  Analysis of induced p53 protein expression on Hela cell 
was detected by using immunocytochemistry technique. Cell 
that stained positive p53 protein showed that there was nucleus 
or cytoplasm stained with brown color,  while the one stained 
negative p53 protein would be purple. From cytotoxicity test 
results of Bruceine A from Bruceine javanica seeds against 
Hela cell, value IC 50  obtained as big as 76.4 µg/ml. From 
observation of p53 protein expression on Hela cells by 
immunocytochemistry staining, it can be seen that Bruceine A 
from Brucea javanica seeds can increase the expression of p53 
protein Hela cells by 44.3%.  From the result of this study,  it 
can be concluded that Bruceine A from Brucea javanica seeds 
have anticancer activity through inhibition mechanism of Hela 
cell proliferation, by activating the tumor suppressor gene such 
as p53. 
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I. INTRODUCTION 
Brucea javanica belongs to the family of Simaroubaceae 
is a shrub which is distributed in Souteast Asia including 
Indonesia [1]. The bioactive component of quassinoid from 
Brucea javanica has an interesting biological effect [2]. 
There were javanicosides, flazin, bruceocides, bruceantine, 
bruceine, brusatol and terpeniod blumenol A. Some with 
glycone or aglycone derivates. The mode of action based on 
inhibition of protein synthesis ([2],[3]). These quassinoid 
were reported for thheir potential to induce human 
promyelocytic leukemia (HL-60) cell differentiationand to 
inhibit cyclooxygenase-1 (COX-1), cyclooxygenase-2 
(COX-2) and 7,12 dimethyl benz[a]antracence (DMBA)-
induced lessions in a mouse mammary organ culture model. 
Bruceantinols  and bruceines have been shown to posses as 
antibabesial activity with IC50 at 5 ng/mL [4]. Bruceantine 
and brusatol have antileukemic effects induced down-
regulate c-myc protein levels [5]. Some quassinoid have 
also been found to exhibit antiplasmodial activity againts 
Plasmodium falciparum [6]. In this study was conducted to 
evaluate cytotoxic activity and induced p53 protein 
expression of Bruceine A  isolated from the seeds of Brucea 
javanica on Hela cell. 
II. METHODOLOGY 
This study is a purely experimental study with by post-
test only control group design approach.  
The seeds of Brucea javanica fruits were purchased and 
collected from Merapi Farma Herbal & Co., Yogyakarta, 
Indonesia. This sample was identified by Department of 
Biology, Faculty of Pharmacy UGM, Yogyakarta. 
The cytotoxic activity was tested by assessing their 
inhibition of growth of cells derived from human cancer [7]. 
The cell lines  tested was Hela cell. Cells are adapted for 
growth in RPMI 1640 media supplemented with 10% 
bovine serum and 60 mg/ml amikacin and maintened 150 
cm2 flasks at 37ºC and 5% CO2. Into 96 micro plate wells 
, contains 100 μl   experimental   cells   with   a   density   of   2 x 
10 4 cells / well, added   100μl   of   Bruceine A  at various 
concentrations  levels  (1000,  500,  250,  100,  50,  10μg  /  ml)  in  
triplicate. As a control, culture media considered to have 
growth of 100% is used. Culture contained the experiment 
material was incubated in an incubator with 5% CO 2 stream 
at 37 ºC for 24 hours. At the end of incubation, each well 
calculated the number of living cells by 
using trypan blue. Cytotoxic activity was analyzed by probit 
analysis, determined the value of IC 50 concentration 
required to inhibit tumor cells up to 50%. 
Detection of p53 protein on Hela cell is done using 
immunohistochemistry test. Cells stained positive p53 
protein showed that there was nucleus or cytoplasm with 
brown color. 
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III. RESULT AND DISCUSSION 
A. Bruceine A cytotoxicity on Hela Cells 
In this cytotoxicity test, method of counting cells 
directly using the aid of trypan blue staining was used, 
which is based the principle that the dead cell has lost its 
membrane integrity, so that trypan blue can enter the cell. 
Thus, the dead cell will absorb the blue color, while the 
living cell does not absorb blue [8] . The average number of 
living Hela cells after Bruceine A addition at various 
concentrations is seen in Table I. From the Table I can be 
seen that the higher the concentration, the greater Bruceine 
A percentage of Hela  cell’s  death.   In   this  cytotoxicity test, 
parameter value IC 50  is determined. IC 50 value indicates 
the toxicity potential of a compound against Hela cell. The 
smaller the value of IC 50 means that the compound is more 
toxic. Toxicity potential of Bruceine A against Hela cell 
shown by IC 50 value of 76.4 µg / ml. 
 
B. Analysis of p53 protein Expression on Hela Cells 
Results of p53 protein detection by 
immunocytochemistry, data were obtained on the number of 
p53 protein expression per 100 cells as presented in Table 
II. The Table II shows the dispose of expression increase of 
p53 protein in the treated group compared to the 
control. The picture of p53 protein expression in Hela cells 
control and treatment with Bruceine A can be seen in Fig. 
1and 2. 
In the Fig.1 and 2 above can be seen that most of the 
Hela cells control showed positive expression of p53 
protein. Thus in Hela cells by adding Bruceine A 
concentration   of   10μg/ml   an   increase   in   the   expression   of  
p53 protein positive is seen. This case indicates that the 
Hela   cell’s   death   through   the   mechanism   of   proliferate  
inhibition, by activating the tumor suppressor gene such as 
p53. Any stress or DNA damage can stimulate the 
expression of p53 protein in Hela cells [9]. 
In Hela cells control or Bruceine A treatment, most of 
p53 protein expression is located at the cell nucleus, 
although some located at the cytoplasm (Table III). The 
existence of positive expression of p53 protein in the 
cytoplasm shows that inhibition of Hela cell growth occurs 
in the G1 phase of the cell cycle. Quassinoid Bruceine A is 
estimated can inhibit cell division in the G1 phase of the cell 
cycle by increasing the expression of p53 protein in the 
cytoplasm. According to [9], p53 gene uses its function 
during the G1 phase of the cell cycle. Most of the p53 gene 
acts as: 'the guardian of the genome', i.e. : (1) level of p53 
rapidly increased in response to DNA damage, (2) lead to 
inhibition of cell cycle during the G1 phase, (3) provide 
time for cells to repair DNA damage, (4) if the damage 
cannot be repaired, p53 will induce programmed cell 
death (apoptosis). 
 
 
 
 
In this study, an antibody that can detect both wild-
type p53 protein and mutant in cancer cells is used. So in 
this study the positive p53 protein expression indicated with 
brown color in the nucleus or cytoplasm that cannot be 
distinguished between the expression of p53 from wild or 
mutant type. 
Both wild-type p53 protein (wild type) and mutant 
migrated in the cell nucleus are known as 
the Nuclear Localization Signals (NLS) attached to their 
primary sequence [10]. According to [11] and [12], wild-
type p53 causes growth inhibition in G1 phase, so that 
means in order cell to enter S phase, p53 should be 
inactivated..    
Overall, it can be concluded that quassinoid Brucein A 
can cause death to Hela cells. The Hela   cell’s   death  
mechanism is through the mechanism of inhibition of Hela 
cell proliferation, as evidenced by an increase in p53 protein 
expression in Hela cells. The expression of the p53 protein 
cannot be distinguished whether wild or mutant type p53, 
but seeing the expression of p53 protein in the cytoplasm 
shows that inhibition of Hela cell proliferation through cell 
cycle progression inhibition that occurs in G1 phase. This 
provides an opportunity for the genes that control DNA 
repair to repair the DNA damage that exists. 
 
TABLE I. THE AVERAGE NUMBER OF LIVING HELA CELLS AND  
HELA CELL’S DEATH PERCENTAGE AFTER  BRUCEINE A ADDITION AT 
VARIOUS CONCENTRATIONS 
 
 
TABLE III. EXPRESSION OF P53 PROTEIN ON HELA CELLS 
CONTROL AND TREATMENT BRUCEIN A CONCENTRATION OF 10 
µG / ML PER 100 CELLS  
 
 
Replication 
Expression of p53 Protein Hela Cells 
Control Bruceine A 
Positive Negative Positive Negative 
I 29.0 74.0 43.0 62.0 
II 19.0 83.0 50.0 56.0 
III 17.0 85.0 49.0 60.0 
Total 65.0 242.0 142.0 178.0 
Percentage (%) 21.1 78.8 44.3 55.6 
Cons. Number of living cells x 10 4   
(µg / 
ml) Bruceine A Control 
% 
Mortality 
  I II III Average I II III Average   
1000 7.5 7.5 6.0 7.0 45.0 46.5 43.5 45.0 84.4 
500 14.0 15.0 12.0 13.5 43.5 64.5 45.0 51.0 73.5 
250 17.0 18.0 15.0 16.5 45.0 48.0 42.0 45.0 63.3 
100 18.0 19.5 19.5 19.0 46.5 37.5 39.0 41.0 53.7 
5 0 29.0 30.0 28.5 29.0 51.0 52.5 55.5 53.0 45.2 
10 38.0 36.0 37.5 37.0 63.0 63.0 52.5 59.5 37.8 
60
TABLE III. LOCATION POSITIVE P53 PROTEIN EXPRESSION IN HELA CELLS 
CONTROL AND BRUCEIN A TREATMENT 
 
 
 
 
 
 
Fig. 1.  Microscopic  picture of  Hela cells control with 
immunocytochemistry staining (magnification 400x).  
 
 
 
 
 
 
Fig. 2.  Microscopic  picture of  Hela cells after Bruceine A treatment with 
immunocytochemistry staining (magnification 400x).  
 
 
IV. CONCLUSION 
In conclusion that Bruceine A from Brucea javanica 
seeds have anticancer activity through inhibition mechanism 
of Hela cell proliferation, by activating the tumor suppressor 
gene such as p53. Anticancer activity test toward Hela cells 
showed the IC50 value of Bruceine  A was 76.4 µg/ml. 
Bruceine A can stimulate the expression of p53 protein in 
Hela cells by 44.3%. 
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